Golden Temple Pharma Llp - Company Profile

It is a chemicals limited liability partnership based in Mumbai, Maharashtra, India, established in 2012.
2012 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Golden Temple Pharma Llp

Golden Temple Pharma Llp, a active limited liability partnership, was established on 28 December 2012 in Mumbai, Maharashtra, India. Engaging in chemicals and chemical products within the chemicals sector, it holds LLPIN: AAB-2904. Registered under ROC Roc Mumbai I. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Shonaal Amar Lulla (Designated Partner), Anisha Sanjeevan Kanjilal (Designated Partner), Geeta Amar Lulla (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at 107/108, Anand Estate, Nm Joshi Marg, Chinchpokli (West),, Mumbai, Maharashtra, 400011.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAB-2904

  • Incorporation Date

    28 December 2012

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai I

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 13 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Golden Temple Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Golden Temple Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Golden Temple Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Shonaal Amar Lulla Designated Partner 28 Dec 2012 Current
Anisha Sanjeevan Kanjilal Designated Partner 28 Dec 2012 Current
Geeta Amar Lulla Designated Partner 28 Dec 2012 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Golden Temple Pharma Llp.

Enhance accessibility to Golden Temple Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Golden Temple Pharma Llp revenue growth over time
Golden Temple Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Golden Temple Pharma Llp?

Unlock access to Golden Temple Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Golden Temple Pharma Llp?

Unlock and access historical data on people associated with Golden Temple Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Golden Temple Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Golden Temple Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Golden Temple Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Golden Temple Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Golden Temple Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was recorded as a recent event.

  • Director Appointment

    Shonaal Amar Lulla was appointed as a Designated Partner was appointed as a Designated Partner on 28 Dec 2012 & has been associated with this company since 13 years 3 months . was recorded as a recent event.

  • Director Appointment

    Progress on Anisha Sanjeevan Kanjilal was appointed as a Designated Partner was appointed as a Designated Partner on 28 Dec 2012 & has been associated with this company since 13 years 3 months . was documented.

  • Director Appointment

    The activity Geeta Amar Lulla was appointed as a Designated Partner was appointed as a Designated Partner on 28 Dec 2012 & has been associated with this company since 13 years 3 months . was completed.

  • LLP Incorporation

    The activity Golden Temple Pharma Llp was registered on 28 Dec 2012 with Roc Mumbai I & aged 13 years 3 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Golden Temple Pharma Llp?

The LLPIN of Golden Temple Pharma Llp is AAB-2904.

Where is Golden Temple Pharma Llp headquartered?

Golden Temple Pharma Llp is headquartered at 107/108, Anand Estate, Nm Joshi Marg, Chinchpokli (West),, Mumbai, Maharashtra, 400011.

When was Golden Temple Pharma Llp incorporated?

Golden Temple Pharma Llp was incorporated on 28 December 2012.

Who are the current directors of Golden Temple Pharma Llp?

The current directors of Golden Temple Pharma Llp are

What is the primary industry of Golden Temple Pharma Llp?

The primary industry of Golden Temple Pharma Llp is Chemicals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available